12:00 AM
Jan 21, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Pfizer sales and marketing update

Pfizer launched Quillivant XR in the U.S. to treat ADHD. FDA approved the once-daily,...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >